Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Ping Wang

Ping Wang, Ph.D.

Ping Wang, Ph.D.

Medical Director, Clinical Chemistry Laboratory
Department of Pathology and Genomic Medicine
The Methodist Hospital Physician Organization
Assistant Member
Houston Methodist Research Institute
Associate Professor of Clinical Pathology and Laboratory Medicine
Weill Cornell Medical College of Cornell University

6565 Fannin Street, Suite M205
Houston, Texas 77030
Phone: 713-441-3294
Email: pwang@houstonmethodist.org


Dr. Wang received her Ph.D. in molecular and cellular pharmacology from the University of Wisconsin in Madison. She then completed a clinical chemistry fellowship at the University of California at San Francisco before assuming her current positions at Houston Methodist in 2007. She also holds an adjunct assistant professor appointment in the Department of Biology and Biochemistry at the University of Houston.

Dr. Wang is board certified in both clinical chemistry and molecular diagnostics by the American Board of Clinical Chemistry. Her research interests are pharmacogenomics, therapeutic drug monitoring, and toxicology. Her current research focuses on using individual genomic data to personalize drug dosing, and she is involved in research projects that focus on biomarker discovery and application of mass spectrometry.

Representative Recent Publications:

  • Shu I, Wang P. A 70-year Old Man with Blue Skin. Clin Chem. 2013, in press.
  • Shu I, Pina-Oviedo S, Quiroga-Garza G, Meng QH, Wang P. Influence of Vitamin D2 Percentage on Accuracy of 4 Commercial Total 25-Hydroxyvitamin D Assays. Clin Chem. 2013 Jun 12. [Epub ahead of print]
  • Shu I, Wang P. Simultaneous serum nicotine, cotinine, and trans-3'-hydroxycotinine quantitation with minimal sample volume for tobacco exposure status of solid organ transplant patients. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jun 1;928:139-45.
  • Shu I, Devaraj S, Hanson SE, Little RR, Wang P. Comparison of hemoglobin A1c measurements of samples with elevated fetal hemoglobin by three commercial assays. Clin Chim Acta. 2012 Oct 9;413(19-20):1712-3.
  • Wang P, Hudspeth E. Increased body mass index but not common vitamin D receptor, PPARg and cytokine polymorphisms confer predisposition to post-transplant diabetes. Arch Pathol Lab Med. 2011 Dec;135(12):1581-4.
  • Wang P. Statin dose in Asians: is pharmacogenetics relevant? Pharmacogenomics. 2011 Nov;12(11):1605-15.
  • Wang P, Mao Y, Razo J, Zhou X, Wong ST, Patel S, Elliott E, Shea E, Wu AH, Gaber AO.¬†Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients. Pharmacogenomics. 2010 Oct;11(10):1389-402.
  • Wang P, Molina CP, Maldonado JE, Bernard DW. In utero drugs of abuse exposure testing for newborn twins. J Clin Pathol. 2010 Mar;63(3):259-61.
  • Wang P, Huang L, Davis JL, Swartzman A, Roth B, Stone J, Wu AH. A hydrophilic-interaction chromatography tandem mass spectrometry method for quantitation of serum s-adenosylmethionine in patients infected with human immunodeficiency virus. Clin Chim Acta. 2008 Oct;396(1-2):86-8.
  • Wu AH, Wang P, Smith A, Haller C, Drake K, Linder M, Valdes R Jr. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations. Pharmacogenomics. 2008 Feb;9(2):169-78.
  • Wang P, Stone JA, Chen KH, Gross SF, Haller CA, Wu AH. Incomplete recovery of prescription opioids in urine using enzymatic hydrolysis of glucuronide metabolites. J Anal Toxicol. 2006 Oct;30(8):570-5.